Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Mulberry raises £20m from key shareholders; FY revenues slump

(Sharecast News) - Luxury handbag maker Mulberry said on Thursday that it has raised £20m from Challice and Frasers Group - its two largest shareholders - as it reported a slump in full-year revenue and a widening of underlying losses. It also said it would raise up to £1.2m from other shareholders.

Mulberry said the net proceeds of the fundraising and retail offer will allow the group to make targeted investments to accelerate its future growth and meet its stated medium-term financial targets.

News of the fundraising came as Mulberry said group revenue in the year to 29 March 2025 fell 21% to £120.4m, "reflecting challenging macroeconomic conditions".

The underlying pre-tax loss widened to £23.7m from £22.6m a year earlier.

UK retail and digital revenue declined 20%, hit by macroeconomic conditions, uncertainty and inflationary pressures which have affected consumer spend and habits, Mulberry said.

Revenue in North America dipped 1%, meanwhile, supported by the opening of the Nordstrom online concession platform and a full-year trading of new Nordstrom stores.

Chief executive Andrea Baldo said: "We have made significant progress in laying the foundations for Mulberry's turnaround. Since launching our 'Back to the Mulberry Spirit' strategy in January, we have acted at pace to simplify the business, reduce costs, and refocus on our most profitable channels and markets. This is an ambitious transformation, underpinned by operational discipline and a commitment to placing creativity at the heart of everything we do.

"Whilst the external environment remains challenging, we are energised by the opportunities ahead and remain focused on restoring profitability and achieving our medium-term targets of over £200m in annual revenue and a 15% adjusted EBIT margin."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.